Cancer Screening: Provider Assessment and Feedback — Breast Cancer
Findings and Recommendations
The Community Preventive Services Task Force (CPSTF) recommends provider assessment and feedback interventions on the basis of sufficient evidence of effectiveness in increasing screening for breast cancer by mammography.
The full CPSTF Finding and Rationale Statement and supporting documents for Cancer Screening: Provider Assessment and Feedback — Breast Cancer are available in The Community Guide Collection on CDC Stacks.
Intervention
Provider assessment and feedback interventions both evaluate provider performance in delivering or offering screening to clients (assessment) and present providers with information about their performance in providing screening services (feedback). Feedback may describe the performance of a group of providers (e.g., mean performance for a practice) or an individual provider and may be compared with a goal or standard.
About The Systematic Review
The CPSTF finding is based on evidence from a Community Guide systematic review published in 2008 (Sabatino, et al., search period through September 2004) combined with more recent evidence (search period 2004 – October 2008).
The systematic review was conducted on behalf of the CPSTF by a team of specialists in systematic review methods, and in research, practice, and policy related to cancer prevention and control. This finding updates and replaces the 2008 CPSTF finding on Cancer Screening: Provider Assessment and Feedback Breast Cancer.
The effectiveness of provider-directed interventions was determined by considering evidence across all three cancer screening sites combined, as long as there were not differences in effectiveness by screening test. This was done because provider behavior was thought to be less influenced than client behavior by the nature of screening tests.
Study Characteristics
- Completed screening outcomes were assessed by medical record review.
- Provider screening performance was assessed via computer search or chart review.
- Feedback was provided concerning individual provider performance, group performance, or both.
- Feedback received by providers varied from a single occurrence to regular intervals.
- Studies of completed screenings were conducted in urban and rural settings in the U.S. and included both trainee and nontrainee physicians.
Summary of Results
The review included nine studies that assessed intervention effectiveness for breast, cervical, and colorectal cancers.
- Screening for breast, cervical or colorectal cancer: median increase of 13.0 percentage points (interquartile interval: 5.5 to 21.8 percentage points; 13 study arms).
- Completed breast cancer screening by mammography: estimated effects ranged from a 3.4 to 20.6 percentage point increase (4 study arms)
Summary of Economic Evidence
The updated search for evidence included studies about breast, cervical, or colorectal cancer screening. Only one study about colorectal cancer screening qualified for the review. Monetary values are presented in 2009 U.S dollars.
- The estimated cost of increasing screening for colorectal cancer among military veterans was $1,074 per additional screening.
Applicability
The recommendation to increase screening for breast cancers should be applicable across various settings and provider training status may be related to magnitude of effect.
Evidence Gaps
The following outlines evidence gaps for provider assessment and feedback to increase breast, cervical, or colorectal cancer screening.
- Can a single assessment and feedback program targeting all three cancer sites increase screening use for each site?
- Are some approaches more effective than others (e.g., group versus individual feedback)?
- Does the magnitude of effect differ for (1) physicians in training versus trained physicians and (2) providers other than physicians?
- What is required to facilitate dissemination and implementation of provider assessment and feedback to healthcare system settings across the United States?
- How are the costs and cost effectiveness of these interventions related to the structural characteristics of the settings of interventions? In particular, can HMOs address logistical problems (e.g., contacting providers and reducing administrative time) more readily than fee-for-service practices, thereby lowering costs and improving cost effectiveness?
- What is the impact of interventions on non cancer related healthcare delivery? For example, does the effect of these interventions spill over into improved delivery of other clinical services?
- What are the incremental effects of adding intervention components to other interventions?
- What influence do newer methods of communication (e.g., the Internet, e-mail, social media, automated interactive voice response, texting) have on intervention effectiveness?
- What is the influence of health system factors on intervention effectiveness?
- Are interventions effective for promoting colorectal cancer screening with methods other than FOBT?
- Are interventions to promote colorectal cancer screening equally effective when specific to one type of test as they are when addressing colorectal cancer screening more generally?
Implementation Considerations and Resources
- While assessment and feedback interventions showed positive effects in both trainee and nontrainee physician populations, there is some evidence to suggest trainees are more responsive.
- Reported barriers to implementation included the following:
- Potential burdens on practices or clinic staff to complete audits and prepare and provide feedback
- Possible sensitivity of some providers to the source of evaluation. Trained physicians may be sensitive to evaluation and criticism from other physicians or insurance companies.
Crosswalks
Healthy People 2030 includes the following objectives related to this CPSTF recommendation.